Health Technology

MedNetOne Health Solutions Is the First Physician Organization in Michigan to Have a Joint Venture with Honest Medical Group

MedNetOne Health

MedNetOne Health Solutions announced it is the first Michigan physician organization to enter into a joint venture with Nashville-based Honest Medical Group, a physician enablement company aimed at improving the health care experience and reducing costs for members with Medicare Advantage.

The announcement was made by MedNetOne co-founders Ewa Matuszewski, CEO, and Al Juocys, D.O., President and Chief Medical Officer. It follows Blue Cross Blue Shield of Michigan's announcement that it would form a joint venture with Honest Medical Group to facilitate independent joint ventures between physician groups such as MedNetOne and Honest Medical Group for risk and revenue sharing.

"This is a huge step in the right direction for Medicare Advantage providers and their patients. Transforming primary care is no longer a dream – it's a reality. And we could not be more excited about where the partnership will take us for the benefit of patients."

Dr. Aric Coffman, CEO of Honest Medical Group

MedNetOne has been tightly connected with payors focusing on innovative, patient-centered quality care programs and its capacity to meet quality performance measures reliably. This emphasis encouraged the company to seek a partnership with the Honest Medical Group earnestly.

MedNetOne provides a wide range of services to independent medical practices, advanced practice physicians, mental health specialists, and chiropractors that are intent on running fully integrated, population-based, patient-centric practices with modern technological infrastructure. In addition, 18% of the population served is at least 65 years old and qualified for or enrolled in a Medicare Advantage plan.

The company tests, develops, and implements novel care management techniques and expanded multidisciplinary team care services, emphasizing providing care for the complete person to people with chronic illnesses such as diabetes, hypertension, obesity, chronic pain, and asthma. Additionally, the company has expanded its offerings to include palliative care.

During the pandemic, MedNetOne established 120 vaccination clinics in schools and ethnic areas and is a partner of the Detroit Equity Coalition on Covid-19.

The organization has recently launched a mobile clinic for community-based treatment, particularly in marginalized regions, to provide primary care services such as chronic illness care, physicals, blood pressure screenings, and immunizations.
 

Spotlight

Other News
Health Technology

Rudolf Riester GmbH Announces Global Market Launch of Telemedicine Solution, Showcases ri-sonic® E-Stethoscope + eMurmur® AI Integration

Rudolf Riester GmbH | January 29, 2024

Rudolf Riester GmbH, a global leader in medical technology, proudly announces the full market launch of its comprehensive Telemedicine offering. Already in active use across Europe, the Middle East, and Africa, the solution from the trusted Riester brand delivers industry-leading quality and versatility through integration of a broad range of medical devices to meet the needs of diverse user scenarios. "Since its founding 75 years ago, Riester has been a pioneer in providing accurate and efficient diagnostic devices for front-line healthcare. We have brought this passion and expertise to the creation of our telemedicine solution," said Dr. Georgiana Gasquères, Global Business Unit Director, Telemedicine at Riester. "Now we empower healthcare providers worldwide with the tools they need to deliver accurate diagnosis and exceptional care to every patient, everywhere, and to do it more sustainably." Riester is demonstrating its Telemedicine Case and Cart offerings at the Arab Health show in Dubai, 29 January – 1 February 2024, at booth SA.E30. Traveling nurses with South African healthcare innovator EQiGate are already evaluating dozens of patients every week with the Riester Telemedicine Case. "EQiGate selected the Riester Telemedicine solution for its high quality, comprehensiveness, and versatile, Windows-based compatibility with our portfolio of operating applications," stated Braam Kruger, CEO at EQiGate. "The Riester solution integrates seamlessly with our Hospital at Home concept, enabling us to bring the hospital to the patient, a healthcare paradigm shift that yields significant cost and time savings for both the healthcare system and the patient." At Arab Health, Riester is showcasing the integration of their industry-leading ri-sonic® E-stethoscope with the eMurmur® AI platform. Digital auscultation with ri-sonic and eMurmur AI enables the early detection and analysis of heart murmurs, informing better, more timely decisions about treatment pathways. To demonstrate their commitment to raising heart health awareness and improving quality of life through accurate and efficient diagnosis, Riester is offering complimentary advisory heart checks to all exhibition attendees at their booth at Arab Health, conducted by a professional cardiologist. "Our participation at Arab Health reaches beyond showcasing our technological advancements; it is about educating and engaging with the public – including Arab Health attendees – and healthcare professionals," said Irina Zhdanova, CEO of Riester. "By providing free advisory heart checks, we emphasise the significance of regular cardiac health assessments and demonstrate how innovative technology can be a pivotal tool in advancing diagnostic cardiac care to improve health outcomes. This is a perfect way to honor Riester’s 75-year heritage and act on our vision and mission." About Rudolf Riester GmbH Since its founding in Germany in 1948, Rudolf Riester GmbH has been a pioneering force in improving quality of life through accurate and efficient diagnosis on the front-line of healthcare. By developing and manufacturing high-quality, market-leading medical diagnostic products, Riester has earned a global reputation for quality, reliability, and innovation in the healthcare sector, with a presence in over 150 countries. Specializing in diagnostic devices, Riester's product portfolio includes telemedicine solutions as well as stethoscopes, blood pressure monitors, otoscopes, ophthalmoscopes, and other medical equipment. Riester is part of the Halma plc group of companies.

Read More

Health Technology, AI

Swoop Launches AI-Powered Conversational Agent for Healthcare Marketing, Revolutionizing Engagement on brand.com

Swoop | January 09, 2024

Swoop, a leader in developing precise direct to consumer (DTC) and healthcare provider (HCP) audiences for pharmaceutical and life sciences brands, today announced the launch of its AI-powered conversational agent. This groundbreaking advancement in healthcare marketing sets a new standard for lower funnel engagement, enabling immediate, MLR-compliant virtual customer interactions via brand.com. “Swoop’s AI-powered conversational agent marks the first groundbreaking advancement for brand.com since the introduction of pharmaceutical websites in the 1990s, addressing a pressing need for innovation in how the industry engages with their customers,” said Scott Rines, underscoring the historic significance of this achievement. “Patients and physicians are looking for real-time information, 24/7/365 during their moment of need, but are often faced with an overwhelming experience on brand.com. They come to the site seeking fast, clear answers to their health-related questions – our agent solves this.” Market conditions continue to remain a challenge with shortages of healthcare professionals despite an uptick in customer demand for information related to their condition and treatment decisions. Meanwhile, HCPs are also less likely to allow medical reps into their offices, a shift that has continued post-Covid. Instead, these increasingly digital-native, often over-extended, physicians prefer to seek information online when their schedule permits, limiting the impact of personal promotion. “The ability to parse the data derived from lower funnel conversations with HCPs and patients in real time will prove invaluable, as these signals will become proprietary 1st party data to optimize future marketing spend and messaging,” added Rines. Key Features of Swoop's Conversational Agent Dynamic Patient Conversations: Patients and HCPs can engage with conversational AI in real-time, creating a personalized and responsive user experience to drive more high-value actions on a health brand website. MLR-Approved Medical Information: Leveraging advanced algorithms, conversational AI provides MLR-approved answers to both simple and complex medical questions in the moment of need, enhancing the overall user experience for both patients and HCPs. Real-Time Patient Insights: Valuable real-time data from conversations accessible via dashboards allows healthcare brands to assess the effectiveness of their messaging and make informed adjustments promptly. Scalable to Client Demands: Whether for a single brand, therapeutic area or product portfolio, Swoop conversational AI agents can scale with the needs of healthcare marketers from new product launches to covering open territories and unsupported brands. Patient Data Security and Compliance: Swoop prioritizes patient privacy and data security, ensuring that all conversational AI agents operate in compliance with the highest industry standards and regulations. Typical Client Results Seen by Customers 96% – Average answer success rate of inquiries 5.2 minutes – Typical conversation duration 4.7/5 – Average user satisfaction rating 800% – Increase in high-value activities on brand websites Swoop’s conversational AI technology is built on more than 1.3 billion conversations with patients and providers and has been trained under the supervision of physicians and medically trained clinicians. Unlike generative AI, which can hallucinate and is not appropriate for direct patient and HCP interaction in the heavily regulated pharmaceutical industry, Swoop conversational AI uses fine-tuned large language models to understand user intent and surface the most relevant MLR-approved answers to ensure compliance, accuracy and, most importantly, safety. About Swoop Swoop, part of Real Chemistry, enables pharmaceutical and life sciences brands to reach their ideal DTC and HCP audiences at crucial moments of their diagnosis and treatment journey. Using ML/AI and real world data, Swoop is a leader in developing brand-exclusive audiences of patients and their providers for healthcare companies. Once the right customers have been targeted, brands can drive bottom-of-the-funnel engagement through Swoop’s proprietary medically trained and MLR-compliant conversational AI. Built on a privacy-by-design foundation, Swoop is both HIPAA-certified and NAI accredited, having developed more than 12,000 unique target audiences for 42 of the top 50 pharmaceutical companies safely. Its conversational AI has been implemented across 100 health brands and trained on over 1.3 billion medical conversations.

Read More

Digital Healthcare, Medical Devices

Mindray Selected as Patient Monitoring Solution Provider for WakeMed Health & Hospitals

Mindray North America | January 12, 2024

Mindray, a global developer of technologies and solutions for patient monitoring, anesthesia, and ultrasound, announced a five-year agreement with WakeMed Health & Hospitals (WakeMed), a leading health system in Raleigh, N.C. The nationally recognized 970-bed not-for-profit health care system selected Mindray's intuitive patient monitoring systems—including the BeneVision Distributed Monitoring System (DMS) and BeneVision N-series Patient Monitoring Systems—for its three hospitals. As part of the agreement, approximately 2,300 monitoring devices will be installed in WakeMed's emergency and inpatient areas, across all acuity levels, to help assess and facilitate patient care, monitor vitals and condition changes in real-time, and provide seamless data integration during patient transport throughout its facilities. "We are very excited to collaborate with WakeMed," stated Wayne Quinn, President, Mindray North America. Wayne continued, "Our purpose is to provide our customers with progressive technology that helps them deliver the highest quality care now and in the future, aligning with a shared vision of better healthcare for all. The contract with WakeMed underscores our commitment to ensuring the health system has access to tools and technologies that enable clinicians to work more efficiently while helping WakeMed fulfill its mission to improve the health and well-being of their community by providing outstanding and compassionate care to all." "Mindray's monitoring technology will allow us to further improve patient safety, efficiency and clinical workflow as we continue to deliver life-changing care," said Neal Chawla, MD, Chief Medical Information Officer (CMIO) for WakeMed. "Alongside comprehensive patient monitoring, these innovative tools help prevent alarm fatigue and create a quieter, more restful environment for patients—a critical element to promote healing." The BeneVision N-Series consists of six monitors with the same user interface. It allows healthcare facilities to choose their ideal display size and parameter capabilities, putting precise, relevant data at clinicians' fingertips. As the first-ever patient monitoring platform to incorporate capacitive touch screen technology across all of its monitors, N-Series enables clinicians to cut minutes off of clinical review, analysis and charting time, leading to increased efficiencies and driving positive patient outcomes. The N-Series' modular design expands, providing a scalable solution and the ability to flex from low acuity to high acuity, seamless data integration during transport, and flexible licensing options. Mindray's BeneVision DMS provides continuous, real-time access and surveillance across large and small healthcare networks and integrates and displays patient information from networked bedside monitors, vital signs monitors, wireless transport solutions, and telemetry transmitters – supporting up to 1,200 devices across the enterprise, locally, and remotely. The BeneVision DMS enables clinicians to observe, manage and document a patient's condition in support of high-quality, patient-centric care, from admission to discharge. About Mindray Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of lifesaving tools across three primary business segments: medical imaging, patient monitoring and life support, and in-vitro diagnostics. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in Silicon Valley, with additional facilities in major international markets around the world. About WakeMed Health & Hospitals Serving the community since 1961, WakeMed is a not-for-profit health care system founded and based in Raleigh, N.C. WakeMed exists to improve the health and well-being of our community by providing outstanding and compassionate care to all. WakeMed's 970-bed system comprises a network of facilities throughout the Triangle area, including three full-service hospitals, seven emergency departments, a dedicated Children's Hospital and Rehabilitation Hospital, more than 90 physician offices and Wake County's only Level I Trauma Center. WakeMed's mission-driven team includes more than 10,300 employees, 1,400 volunteers and 1,300 affiliated physicians, along with the more than 700 physicians and providers with WakeMed Physician Practices – all representing the best minds and the biggest hearts and the finest quality in health care and community health.

Read More

Health Technology

Axxess Launches New Axxess Connect Solution to Accelerate Health Information Exchange

Axxess | January 23, 2024

Axxess, the leading global technology innovator for healthcare at home, launched a new product called Axxess Connect, a groundbreaking interoperability solution. This new product will revolutionize the way Axxess users connect and share data with healthcare providers and specialists, further enhancing care coordination, improving patient outcomes and driving the future by enabling new care models and value-based care. "Axxess Connect is a new benchmark for interoperability in healthcare," says Tim Ingram, Executive Vice President of Interoperability at Axxess. "By working with our partner Kno2 we can now connect our solutions to help accelerate the exchange of health information securely across any network. This means our clients will have easier access to a broader range of providers and specialists, making data sharing and referrals more efficient." By being Kno2 Connected™, Axxess Connect, enables the secure, effortless, and maximized exchange of patient information across patients, providers, payers and HIT vendors. ­­­­The solution meets data security and compliance requirements in accordance with HITRUST and HIPAA regulation for privacy, data sharing and healthcare communication standards supported by national and regional frameworks including Direct Trust, Carequality and most recently, TEFCA. This ensures that patient data is interoperable, secured and protected when shared across systems. "Our collaboration with Kno2 not only improves the overall experience for our users, but it also reduces the administrative load on healthcare providers," said Ingram. "By minimizing time spent on administrative tasks, our clients can focus more on providing quality patient care." Added Theresa Bell, Co-founder, President and Chief Technology Officer of Kno2: "By seamlessly connecting Axxess users with healthcare providers and specialists, we are breaking down barriers and revolutionizing the way data is shared in every care setting. Axxess Connect represents the power of the partnership and the value of being Kno2 Connected. Together, we are revolutionizing care delivery and thoughtfully solving healthcare's biggest problems." Axxess Connect will first be available to Axxess Palliative Care clients before eventually being rolled out to the entire Axxess suite of solutions for home health, hospice and home care. About Axxess Axxess is the leading global technology innovator for healthcare at home, focused on solving the most complex industry challenges. Trusted by more than 9,000 organizations that serve more than 5 million patients worldwide, Axxess offers a complete suite of easy-to-use software solutions that empower home health, home care, hospice, and palliative providers to make healthcare in the home human again. Multiple independent certifications have confirmed that Axxess has the most secure and industry-compliant software available for providers. The company's collaborative culture focused on innovation and excellence is recognized nationally as a "Best Place to Work."

Read More